BIORESTORATIVE THERAPIES, INC. (BRTX) Return on equity 2021–2025
BIORESTORATIVE THERAPIES, INC. (BRTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-3992.2%FY2025 · since FY2021: -410.9% → -3992.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3992.2% | -3887.0 pp |
| FY2024 | -105.3% | -1.1 pp |
| FY2023 | -104.1% | +24.4 pp |
| FY2022 | -128.5% | +282.4 pp |
| FY2021 | -410.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BRTX financial trends
BRTX RevenueBRTX Net incomeBRTX Net marginBRTX Gross profitBRTX Gross marginBRTX Operating incomeBRTX Operating marginBRTX Operating cash flowBRTX Free cash flowBRTX Capital expendituresBRTX Stock buybacksBRTX Dividends paidBRTX Total assetsBRTX Total liabilitiesBRTX Shareholders’ equityBRTX overview →